KetamineOne Capital Limited

Company Profile

KetamineOne Capital Limited had its IPO on under the ticker symbol KONEF.

The company operates in the Healthcare sector and Medical Care Facilities industry. KetamineOne Capital Limited has a staff strength of 0 employees.

Stock update

Shares of KetamineOne Capital Limited opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a 0% increase from the previous day's closing price.

A total volume of 46,520 shares were traded at the close of the day’s session.

In the last one week, shares of KetamineOne Capital Limited have increased by +9.3%.

KetamineOne Capital Limited's Key Ratios

KetamineOne Capital Limited has a market cap of $41.68 million, indicating a price to book ratio of 0.9481 and a price to sales ratio of 6.7407.

In the last 12-months KetamineOne Capital Limited’s revenue was $6.44 million with a gross profit of $424244 and an EBITDA of $-24302326. The EBITDA ratio measures KetamineOne Capital Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, KetamineOne Capital Limited’s operating margin was -388.55% while its return on assets stood at -79.93% with a return of equity of -656.27%.

In Q2.3333333333333, KetamineOne Capital Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 2.6%.

KetamineOne Capital Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into KetamineOne Capital Limited’s profitability.

KetamineOne Capital Limited stock is trading at a EV to sales ratio of 0.2844 and a EV to EBITDA ratio of -0.0389. Its price to sales ratio in the trailing 12-months stood at 6.7407.

KetamineOne Capital Limited stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0

Total Liabilities

$5.38 million

Operating Cash Flow

$-1505350.00

Capital Expenditure

$12982

Dividend Payout Ratio

0%

KetamineOne Capital Limited ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.

KetamineOne Capital Limited ended 2024 with $2.44 million in deferred long-term liabilities, $5.38 million in other current liabilities, 45173256.00 in common stock, $-63227506.00 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

KetamineOne Capital Limited’s total current assets stands at $1.42 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $756657.00 compared to accounts payable of $3.28 million and inventory worth $0.

In 2024, KetamineOne Capital Limited's operating cash flow was $-1505350.00 while its capital expenditure stood at $12982.

Comparatively, KetamineOne Capital Limited paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0

52-Week High

$0.0794

52-Week Low

$0.0036

Analyst Target Price

$

KetamineOne Capital Limited stock is currently trading at $0 per share. It touched a 52-week high of $0.0794 and a 52-week low of $0.0794. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.01 and 200-day moving average was $0.01 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.